Test Price
2,800 AED✅ Home Collection Available
AICDA Gene (Immunodeficiency with Hyper-IgM Type 2) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين AICDA (نقص المناعة مع فرط IgM النوع الثاني) بتقنية التسلسل الجيني المتقدّم (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
يضمن مختبرنا المعتمد من هيئة الصحة بدبي دقةً تشخيصيةً بنسبة 99.9%، مع استشارة وراثية شاملة وفق بروتوكول DHA.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
- ✓ Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by a certified immunologist.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Overview
The AICDA gene NGS test detects pathogenic variants responsible for Hyper‑IgM syndrome type 2, a severe primary immunodeficiency. Using Next Generation Sequencing, it provides definitive molecular diagnosis, enabling early intervention and personalized management under DHA‑approved protocols.
| Feature | Our Test (NGS) | Closest Alternative (Sanger) |
|---|---|---|
| Precision | 99.9% Sensitivity & Specificity | ~95% Sensitivity, limited to single exon mutations |
| Methodology | NGS – full gene coverage, copy‑number variant detection | Capillary sequencing, no copy‑number assessment |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Clinical Interpretability | Includes pathogenicity classification (ClinGen/ACMG) | Variant calls only, no clinical annotation |
Physician Insight & Safety Protocol
“As your consultant immunologist (DHA: 61713011), I understand the emotional weight of a possible immunodeficiency diagnosis. This test provides critical genetic evidence, but it must be correlated with your immunological work‑up and clinical history. Always review the results with your treating specialist before altering any therapy.”
— Dr. PRABHAKAR REDDY, Senior Clinical Immunologist
Medication Warning
Do not discontinue prescribed medication or immunoglobulin therapy without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Active severe infection requiring hospitalization.
- Inability to provide informed consent (for minors, legal guardian consent is mandatory per UAE CDS Law 2026).
- If any of the following occur after sample collection, seek immediate medical attention: fever >38.5 °C, severe respiratory distress, or signs of sepsis.
Patient FAQ & Clinical Guidance
What is the purpose of the AICDA gene test?
Key: This genetic test detects AICDA mutations for Hyper‑IgM syndrome type 2, guiding early treatment decisions.
يكشف هذا الاختبار الطفرات الجينية في جين AICDA المرتبطة بمتلازمة فرط IgM النوع الثاني، مما يمكّن من التشخيص المبكر والعلاج الموجّه.
How is the test performed and what does it entail?
Key: At‑home blood sampling and NGS analysis detects AICDA mutations with 99.9% accuracy for reliable diagnosis.
يتم سحب عينة دم بسيطة في المنزل ثم تحليلها بتقنية التسلسل الجيني المتقدم (NGS) في مختبر معتمد من هيئة الصحة بدبي، مما يضمن دقة تصل إلى 99.9%.
What happens if the result is positive?
Key: A positive result confirms Hyper‑IgM type 2, necessitating immunoglobulin replacement therapy and lifelong infection prophylaxis.
يؤكد التشخيص متلازمة فرط IgM النوع الثاني ويستوجب العلاج التعويضي بالغلوبولينات المناعية والوقاية من العدوى مدى الحياة تحت إشراف طبي متخصص.
Pre‑ requirement: A genetic counselling session to draw a pedigree chart of affected family members is mandatory. Provide complete clinical history and report any bleeding disorders or anticoagulant use.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians